Endomag

Endomag, a Hologic company based in the UK, specializes in medical technology focused on improving breast cancer surgical guidance. Founded in 2007 from research at University College London and the University of Houston, Endomag develops wireless solutions that enhance tissue localization and lymphatic tracing. Their mission is to elevate the standard of care for breast cancer patients, with over 500,000 patients treated and products used in more than 1,350 hospitals across 45 countries. The company's core platform, the Sentimag® system, is a non-radioactive surgical guidance tool that detects magnetic markers during tumor removal. Key products include Magseed®, a magnetic seed marker for pre-surgical localization, and Magtrace®, an injectable for lymphatic tracing in minimally invasive procedures. Endomag's technologies provide alternatives to traditional radioactive methods, aiming to optimize surgical outcomes and reduce unnecessary surgeries for the 2 million women diagnosed with breast cancer each year.